Back to top
more

VanEck Pharmaceutical ETF: (PPH)

(Delayed Data from NASDAQ) As of Sep 17, 2021 03:55 PM ET

 Add to portfolio

$73.14 USD

73.14
70,993

-0.57 (-0.77%)

Volume: 70,993

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

ETF Quote Details

Previous Close 73.71
Open 73.45
Bid 71.45
Ask 74.53
Day Low-High 72.97-73.45
52wk Low-High 58.36-77.46
Volume 70,993
NAV (month end) 76.02
Premium (+)/Discount (-) (month end)-2.31

Zacks Premium Research for PPH

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

Hold 3
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

Med
ETF Research Report

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $1.15 (1.57%)
Issuer VAN ECK

Benchmark for PPH

MVIS US LISTED PHARMACEUTICAL 25 INDEX

The MVIS US Listed Pharmaceutical 25 Index tracks the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Fund Summary for PPH

VANECK PHARMACEUTICAL ETF

The VanEck Pharmaceutical ETF replicates as closely as possible, before fees and expenses, the price and yield performance of MVIS US Listed Pharmaceutical 25 Index.